Genprex Inc
Veridion Score
Composite trend over time
Why is GNPX moving today?
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for GNPX.
GNPX insider activity
Genprex Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$35K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | 2026-04-14 | LONGNECKER BRENT M | Insider | sell | $1.23 | 10 | Not reported | $12 | SEC Form 4 |
| 2026-04-15 | 2026-04-14 | LONGNECKER BRENT M | Insider | sell | $1.23 | 8 | 9,157 | $10 | SEC Form 4 |
| 2026-02-27 | 2026-02-27 | Berger Mark Stanley | Insider | sell | $2.00 | 7,168 | 21,692 | $14K | SEC Form 4 |
| 2026-02-27 | 2026-02-27 | Confer Ryan M. | Insider | sell | $2.00 | 9,330 | 36,331 | $19K | SEC Form 4 |
| 2025-07-01 | 2025-06-30 | Berger Mark Stanley | Insider | sell | $0.23 | 4,500 | 17,971 | $1K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 1 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moGNPX contract awards, year to date.
Public federal awards linked to this ticker.
GNPX lobbying filings, year to date.
Registered lobbying filings matched to Genprex Inc.